TP53 mutation imaging study for Li-Fraumeni syndrome
Part of Cancer, Genetic & congenital, Hormones & metabolism clinical trials.
This study takes special body images (MRI) in people from families with Li-Fraumeni syndrome, especially those who carry a TP53 gene mutation. The goal is to see whether MRI can help spot problems earlier in a higher-risk group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re from a family with Li-Fraumeni syndrome (LFS).
- You have a known TP53 mutation, or you are required to carry that mutation in your family.
- You can safely have an MRI scan (no unsafe metal/implants for MRI).
- You don’t have an implanted device or prosthesis that can be affected by the MRI magnet (for example, certain pacemakers or metal fragments).
- You can tolerate the MRI room even if you feel anxious in small spaces (claustrophobia should be manageable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special scan (FCH-PET-CT) to help doctors see prostate cancer more clearly in men who have a known gene change involved in DNA repair. It’s meant to improve staging and assessment, especially around when imaging is needed.
This early-phase study uses advanced PET/MRI scans to monitor how immunotherapy treatment works in people with triple-negative breast cancer that is PD-L1 positive. It may help doctors better track tumor changes in the body over time.
This Phase 1 study uses special whole-body imaging scans (PET with CT, plus MRI) to look for signs of acute myeloid leukemia outside the bone marrow. It may help doctors better see where leukemia is and guide future care.
This study uses a special type of PET/MRI scan to look for a common genetic change (IDH mutation) in brain tumors (gliomas). The goal is to improve how doctors diagnose and treat these tumors.
This study tests whether a combined PET/MRI scan can better find and see liver tumors or cancer that has spread to the liver. If you are eligible, you will get this special imaging test, which may help doctors diagnose and plan your treatment more accurately.
This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.
Hear when a new Li-Fraumeni Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.